Standard product description | Projected requirement (singles)/ ICU stay (12.4 days) | Trust stock (singles) | Wholesale stock (singles) | Total stock (singles) | No. of patients treatable with available stock (12.4 day ICU stay) |
Atracuriumbesilate 250 mg/25 mL solution for injection vials | 12 | 50 | 50 | 100 | 8.3 |
Atracuriumbesilate 25 mg/2.5 mL solution for injection ampoules | 114 | 1000 | 2000 | 3000 | 26.3 |
Atracuriumbesilate 50 mg/5 mL solution for injection ampoules | 57 | 3000 | 4000 | 7000 | 122.8 |
The approximate number of patients that can be treated with available stock can be calculated based on the treatment assumptions shown in table 1.The stock data is for illustration purposes only.